For those of you that have been following the news, you have heard about the new low-cost prices that are the norm in the health care sector. The latest news is that the prices of the top-ranked brand name drugs have dropped significantly in recent months. A pharmaceutical company has been able to reduce prices to a point where the price has dropped to a level that the manufacturer feels is affordable.
This is great news for patients.
This price reduction is in part due to the fact that the generic drugs are so much cheaper than the branded ones. The branded drugs have become so expensive that they are not affordable for the average American. The fact that the generic drugs have to be priced so much lower because they are so much cheaper means that a competing drug company can compete against the major brand name drug companies in price at the same point that it is affordable for the average American.
The major brands, such as Eli Lilly and Glaxo Smith-Kline, are also now the major pay-for-play drug companies. To compete against them, the low-cost generic drugs have to be priced too low to be affordable for the average American. So in this example, the generic drug companies can effectively threaten to stop competing with the major brand name drug companies if they cannot increase their prices to a level that is affordable for average Americans.
This is a good example of a high-cost game, and it doesn’t go to the head of the company. As long as we don’t have more money than the average American, we won’t be able to fight them, and we won’t be able to compete against them.
The solution is not to get the drug companies to stop competing with the drug companies, but to put the drug companies in a position to prevent the drug companies from competing with the drug companies. This is our strategy, and we don’t want to get into that. But that’s just our strategy. And we don’t want to take that option. So we’re going to try to do that.
This is where the “take it or leave it” question comes into play. Some countries have tried to make the drug companies compete with one another by offering them cheaper prices, but the result has been that the drug companies have had to become so big they can’t compete with them if they offer cheaper prices. The result is that the prices of the drugs have gone up, and the drug companies have had to find a way to make more money.
This is one of those situations where the drug companies have had to up their prices to compete with the competition.
As it turns out, the prices on drugs have gone up because the competition has made it too expensive to manufacture the drugs. By making the drugs more expensive, the drug companies have forced the countries that make them to make the drugs cheaper, or else they won’t survive the competition. That’s why in our game, we have to make the drugs more expensive so that countries that manufacture the drugs have to make more money.